Fig. 3From: Pharmacodynamics of efavirenz 400 mg in treatment-naïve Chinese HIV-infected patients in a prospective cohort studyVirological responses in HIV-infected individuals commenced on EFV 400 mg. The decrease of HIV RNA load a and proportion of patients who achieved virological suppression at different time-points b were recordedBack to article page